Saeed Dabestani

Filter

2019
Intensive Imaging-based Follow-up of Surgically Treated Localised Renal Cell Carcinoma Does Not Improve Post-recurrence Survival: Results from a European Multicentre Database (RECUR)
Dabestani, S., Beisland, C., Stewart, G. D., Bensalah, K., Gudmundsson, E., Lam, T. B., Gietzmann, W., Zakikhani, P., Marconi, L., Fernandéz-Pello, S., Monagas, S., Williams, S. P., Torbrand, C., Powles, T., Van Werkhoven, E., Meijer, R., Volpe, A., Staehler, M., Ljungberg, B. & Bex, A., 2019, I: European Urology. 75, 2, s. 261-264
Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

Öppen tillgång
2018

A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations
Bex, A., Albiges, L., Staehler, M., Bensalah, K., Giles, R. H., Dabestani, S., Hofmann, F., Hora, M., Kuczyk, M. A., Lam, T. B., Marconi, L., Merseburger, A. S., Fernández-Pello, S., Tahbaz, R., Abu-Ghanem, Y., Volpe, A., Ljungberg, B., Escudier, B. & Powles, T., 2018, I: European Urology. 74, 6, s. 849-851 3 s.
Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

Forskningsoutput